CordovaCann (LVRLF) Gross Margin (2018 - 2019)

CordovaCann (LVRLF) recorded quarterly Gross Margin of 192.41% in Q2 2019, up 699.13% quarter-over-quarter from 24.08% in Q1 2019.

CordovaCann (LVRLF) Gross Margin (2018 - 2019) Analysis & Trends

CordovaCann's Gross Margin history runs 2 years deep, the most recent figure standing at 192.41% for Q2 2019.

In Q2 2019, Gross Margin changed N/A year-over-year to 192.41%; the TTM figure through Jun 2019 stood at 12727.6% (changed N/A YoY), while the FY2025 annual figure was 29.24%, down 31.0% from the prior year.
Gross Margin was 192.41% for Q2 2019 at CordovaCann, up from 24.08% in the prior quarter.
In the past five years, Gross Margin ranged from a high of 192.41% in Q2 2019 to a low of 6.05% in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	49.52%
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	71.66%
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	82.93%
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	49.50%
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	98.31%
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	57.26%
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-293.83%
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	65.25%
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	61.20%
10	CordovaCann	-	-	-	-

Download Data